LGALS3 / Galectin 3 Antibody (clone B2C10)
Primary AntibodyLSBio Guarantee
| Antibody: | Mouse Monoclonal |
| Applications: | Flow Cytometry, Functional Assay, Immunohistochemistry (general), Immunohistochemistry, Frozen, Immunohistochemistry, Paraffin, Western Blot |
| Reactivity: | Human, Mouse |
| Format: | Liquid |
$601.00each
Catalog Number: LS-C140105-100
Catalog Number: LS-C140105
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- Galectin 3 antibody LS-C140105 is an unconjugated mouse monoclonal antibody to Galectin 3 (LGALS3) from human. It is reactive with human and mouse. Validated for Flow, Func, IHC and WB. Cited in 1 publication.
- Application
- FC, Func, IHC, IHC-F, IHC-P, WB
- Reactivity
- Hu, Ms
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Monoclonal Antibodies
- Alternative Names
- 35 kd lectin | 35 kDa lectin | CBP35 | GAL3 | Galactoside-binding protein | GALIG | IgE-binding protein | Laminin-binding protein | Gal-3 | GALBP | MAC-2 | Mac-2 antigen | L31 | MAC2 | CBP 35 | Galactose-specific lectin 3 | Galectin-3 | L-31 | Lectin L-29 | LGALS3
- UniProt Number
- P17931
- NCBI GenBank
- NM_002306 | NP_002297.2
- SwissProt
- P17931
Target
- Target
- Human LGALS3 / Galectin 3
- Antigen Species
- Human
- Epitope
- Human LGALS3 / Galectin-3
- Gene Name
- LGALS3
Antibody
- Host Species
- Mouse
- Clonality
- Monoclonal
- Clone
- B2C10
- Isotype
- IgG1
Immunogen
- Immunogen
- Recombinant human galectin-3.
- Immunogen Type
- Recombinant Immunogen
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, 0.1% BSA
- Preservative
- No
- Purification Method
- Other
Storage & Handling
- Storage Conditions
- Store at 4°C, stable for 1 year.
- Recommended Storage Buffer
- PBS
Blockade of N-Glycosylation Promotes Antitumor Immune Response of T Cells. Shigemi Sasawatari, Yuki Okamoto, Atsushi Kumanogoh, Toshihiko Toyofuku. Journal of immunology (Baltimore, Md. : 1950). 2020 March;204:1373-1385. PubMed: 31969386